SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Synthetic Blood International, Inc. (SYBD) -- Ignore unavailable to you. Want to Upgrade?


To: Terry Vellequette who wrote (25)3/29/1999 9:17:00 AM
From: Micro-Selector  Read Replies (1) | Respond to of 91
 
GREAT info!

As the last of the companies to enter clinical trials for a PFC blood-substitute product, SYBD may be in the best position as it has the advantage of incorporating the failures of prior attempts into its development strategy.

Plus, with a portfolio of products, SYBD is not in a better position to have revenues from the other two products if there are delays getting approval for the blood substitute.